Showing 1 - 9 results of 9 for search 'Neal Bhatia', query time: 0.08s Refine Results
  1. 1
    Local skin reactions and the onset of influenza-like signs and symptoms induced by imiquimodCapsule Summary

    Local skin reactions and the onset of influenza-like signs and symptoms induced by imiquimodCapsule Summary by Neal Bhatia, MD

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Biomarkers in Cutaneous Keratinocyte Carcinomas

    Biomarkers in Cutaneous Keratinocyte Carcinomas by Erica Montano, Neal Bhatia, Jelena Ostojić

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Quality of life and patient-reported symptoms in a Phase 4, real-world study of tildrakizumab in patients with moderate-to-severe psoriasis: Week 28 interim analysis

    Quality of life and patient-reported symptoms in a Phase 4, real-world study of tildrakizumab in patients with moderate-to-severe psoriasis: Week 28 interim analysis by Neal Bhatia, Jayme Heim, Brad Schenkel, J. Gabriel Vasquez

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Long-term quality of life outcomes from a phase 4 study of tildrakizumab in patients with moderate-to-severe plaque psoriasis in a real-world setting

    Long-term quality of life outcomes from a phase 4 study of tildrakizumab in patients with moderate-to-severe plaque psoriasis in a real-world setting by Neal Bhatia, Jayme Heim, J. Gabriel Vasquez, Tina Bhutani, Brad Schenkel, Ranga Gogineni, John Koo

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Improvements in Psoriasis-Related Work Productivity with Tildrakizumab: Results from a Phase 4 Real-World Study in Patients with Moderate-to-Severe Plaque Psoriasis

    Improvements in Psoriasis-Related Work Productivity with Tildrakizumab: Results from a Phase 4 Real-World Study in Patients with Moderate-to-Severe Plaque Psoriasis by Tina Bhutani, John Koo, Jayme Heim, Neal Bhatia, Jacob Mathew, Thomas Ferro, J. Gabriel Vasquez

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    Dermal sensitization, safety, and tolerability of triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel from three clinical trials

    Dermal sensitization, safety, and tolerability of triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel from three clinical trials by Zoe D. Draelos, Emil A. Tanghetti, Leon H. Kircik, Neal Bhatia, Joshua A. Zeichner, Jeffrey L. Sugarman, Linda Stein Gold

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  7. 7
    A Review of the Diagnostic and Therapeutic Gaps in Rosacea Management: Consensus Opinion

    A Review of the Diagnostic and Therapeutic Gaps in Rosacea Management: Consensus Opinion by James Del Rosso, Hilary Baldwin, Neal Bhatia, Rajeev Chavda, Jean Phillipe York, Julie Harper, Firas George Hougeir, J. Mark Jackson, Omar Noor, David A. Rodriguez, Todd Schlesinger, Jonathan Weiss

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  8. 8
    Safety and tolerability of tirbanibulin ointment 1% treatment on 100 cm2 of the face or scalp in patients with actinic keratosis: A phase 3 studyCapsule Summary

    Safety and tolerability of tirbanibulin ointment 1% treatment on 100 cm2 of the face or scalp in patients with actinic keratosis: A phase 3 studyCapsule Summary by Neal Bhatia, MD, Edward Lain, MD, Abel Jarell, MD, Janet DuBois, MD, Maria Luisa Tamarit, MD, Meritxell Falques, MSc, Vera Kiyasova, MD, PhD, Laura Padullés, PhD, Raquel Otero, PhD, Andrew Blauvelt, MD, MBA

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  9. 9
    Triple Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Acne: Efficacy and Safety from a Pooled Phase 3 Analysis

    Triple Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Acne: Efficacy and Safety from a Pooled Phase 3 Analysis by Leon H. Kircik, Linda Stein Gold, Michael Gold, Jonathan S. Weiss, Julie C. Harper, James Q. Del Rosso, Christopher G. Bunick, Neal Bhatia, Emil A. Tanghetti, Lawrence F. Eichenfield, Hilary Baldwin, Zoe D. Draelos, Valerie D. Callender, George Han, Melinda J. Gooderham, Neil Sadick, Mary P. Lupo, Edward (Ted), William Philip Werschler

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: